baber/WOPTO huggingface dataset:
Patent DE-69406554-D1 (DE)
Inventor: STUART RICHARD
IPC: B29C48/395
Filed: 1994-12-07
Granted: 1997-12-04
Abstract: Disclosed is a process for the production of low molecular weight grafted polyolefins in which a molten polyolefin is grafted by reactive processing in a screw extruder at an elevated pressure. The molten polyolefin has a low viscosity and flows easily around the screw, thus the pressure is maintained in the screw extruder apparatus by the use of a pressure control device at the exit end of the extruder.
Patent DE-69428361-D1 (DE)
Inventor: STOCKEL IVAR H
IPC: D21C5/02
Filed: 1994-07-19
Granted: 2001-10-25
Abstract: An improved method of processing baled waste material containing waste paper having fibers contaminated to various degrees for recovering usable cellulosic fiber pulp from the bale in which the bale contents are impregnated with a fiber swelling and debonding fluid by enclosing the bale within a closed chamber and subjecting the chamber and contained bale to multiple pressure environmental conditions, that preferably includes a vacuum, while submerging the bale in the debonding fluid. The impregnated bale contents are allowed to soak for a sufficient period that the lesser degree contaminated fibers become swollen after which the bale is subjected to a sufficiently low degree of pulping agitation as initiates separation of the swollen fibers without significant damage to the fibers and which does not significantly decrease the sheet size of higher degree contaminated bonded fibers and other contaminants. The agitated bale contents are separated in a screen separator into a pulp containing slurry and a reject mass of higher degree contaminated, unswollen fibers and contaminants. If the reject mass contains a significant degree of fibrous material, it is compressed into bale form and again subjected to a multiple pressure liquid impregnation treatment in a closed chamber after which the multiple pressure impregnated bale is subjected to the same or similar recycling operations in separating out the fiber pulp slurry.
Patent DE-69429788-D1 (DE)
Inventor: SVEDMAN PAL
IPC: A61B5/00
Filed: 1994-12-01
Granted: 2002-03-14
Abstract: Apparatus (301) is disclosed for use in sampling transdermal perfusion exudate from a de-epithelialised skin erosion. The apparatus comprises an enclosure defining a sampling chamber (307), securing means (306) operable to sealingly secure a contact surface of the enclosure to an area of skin peripheral to the erosion and an aperture (6) defined in the contact surface and communicating with the sampling chamber. The apparatus also comprises an outlet (310) which communicates with the sampling chamber for the outflow of exudate, an openable closure (311) for the outlet and means (309) for applying suction to the sampling chamber to enhance the rate at which exudate is produced.
Patent DE-69431245-D1 (DE)
Inventor: GLAZE BRADLEY S
IPC: C22B61/00
Filed: 1994-04-06
Granted: 2002-10-02
Abstract: Disclosed is a method for accelerated bioremediation when treating contaminated material containing hydrocarbons by employing chemical and/or biological admixtures, wherein the method comprises (a) supplying contaminated hydrocarbon-containing material to be treated, (b) generating a carrier air flow at a velocity being sufficient for entraining the treated contaminated hydrocarbon-containing material, (c) entraining the treated contaminated hydrocarbon-containing material with air flow, (d) micro-fractionating of the treated contaminated hydrocarbon-containing material and (e) liberating the micro-fractionated treated contaminated hydrocarbon-containing material from air flow for the purpose of accelerated bioremediation of the treated contaminated hydrocarbon-containing material under conditions being sufficient for the accelerated bioremediation process.
Patent DE-69500067-D1 (DE)
Inventor: DROUOT SYLVIE
IPC: G11C16/24
Filed: 1995-02-23
Granted: 1996-11-21
Abstract: The integrated circuit (1) has memory circuits (2) comprising floating grid (3) and isolating (4) transistors in series with a resistor (25) and potential source (Vcc). The memory circuits may constitute an open circuit or a resistance and ar polarised by a circuit (8) having a command signal (VBO) and output (VB). The polarising time constant may be reduced by introducing a second polarising circuit (9) which has two transistors (23,24) types P,N respectively in series to form an invertor. This second polarising circuit is placed in parallel with the first polarising circuit (8).
Patent DE-69500216-D1 (DE)
Inventor: BETTINELLI FABIO
IPC: B65H9/10
Filed: 1995-02-17
Granted: 1997-05-15
Abstract: The clamp consists of two lateral supporting plates (10,12) connected by a cross-member (14). A lower rod (20) can slide transversely in a groove (16) in the cross-member, and is equipped with guides (21) movable in elongated apertures (18). One end of the rod is equipped with an extension (24) which passes through the lateral supporting plate (12) and a bearing (25) fixed to the plate. The end of the extension is in the shape of a fork (28) which holds a roller (26) following the surface of a cam (30). The clamp also has a bar (40) and an arm (41) which engages with a drive shaft and transmits a rotation to the bar.
Patent DE-69500472-D1 (DE)
Inventor: SIERRA LIGIA
IPC: C01B37/06
Filed: 1995-01-26
Granted: 1997-09-04
Abstract: New microporous crystalline solids comprising aluminophosphates substd. in the framework by a metal Me (MeAPO) or by a metal Me and silicon (MeAPSO) of the type having a molar compsn. of the framework which, expressed as oxide, is defined by the formula (MexAlyPz(O)2 for the MeAPO and (MexAluPvSiw)O2 for the MeAPSO, in which x,y,z,u,v and w represent the mol. ratios of the various elements where x = 0.001-0.15, y = 0.34-0.51, z = 0.49-0.51, u = 0.30-0.51, v = 0.30-0.51, w = 0.001-0.20, x+y+z = 1 and x+u+v+w = 1. The solids have a FAU type structure.
Patent DE-69502916-D1 (DE)
Inventor: STAUDER FRANCOIS
IPC: B23K9/23
Filed: 1995-12-04
Granted: 1998-07-16
Abstract: A process for the fusion welding of spheroidal graphite iron components comprises: (i) preheating to a temp. 230-300 degrees C; (ii) fluxing the zone of the component to be welded; (iii) applying a thermal treatment at a temp. 800-920 degrees C for an appropriate duration; (iv) subjecting to a cooling cycle; and (v) subjecting the fluxed area to a further preheating stage at 130-200 degrees C temp. before welding.
Patent DE-69514935-D1 (DE)
Inventor: LINDBERG CAROLINE
IPC: C22C38/12
Filed: 1995-11-21
Granted: 2000-03-09
Abstract: PCT No. PCT/SE95/01377 Sec. 371 Date May 19, 1997 Sec. 102(e) Date May 19, 1997 PCT Filed Nov. 21, 1995 PCT Pub. No. WO96/16759 PCT Pub. Date Jun. 6, 1996The invention concerns an iron-based powder for powder-metallurgically producing components by powder compacting and sintering. The powder contains 0.25-2.0% by weight of Mo, 1.2-3.5% by weight of Mn, 0.5-1.75% by weight of Si and 0.2-1.0% by weight of C and not more than 2% by weight of impurities including less than 0.25% by weight of Cu. The invention also includes a method for preparing sintered components from this iron powder, as well as the sintered products.
Patent DE-69515652-D1 (DE)
Inventor: BRAKIER-GINGRAS LEA
IPC: C07H21/04
Filed: 1995-03-28
Granted: 2000-04-20
Abstract: The invention relates to the use of antisense DNA oligomers to decrease the occurrence of ribosomal frameshifting required for the production of HIV enzymatic proteins when translating HIV messenger RNA, which should interfere with the production of virions and disrupt HIV life cycle. The antisense DNA oligomers are complementary to regions of the RNA of the small ribosomal subunit of mammalian cells, which are involved in the control of translation fidelity.
Patent DE-69516821-D1 (DE)
Inventor: PISANI GIANLUIGI
IPC: D02G3/42
Filed: 1995-12-07
Granted: 2000-06-15
Abstract: The speed reduction system, for the machine component groups in a machine for the prodn. of chenille yarns, has an initial shaft (2) with three cylindrical toothed wheels (R2, R3, R8). One wheel (R2) is powered by a drive wheel on the motor shaft. A second shaft (6) has two toothed cylindrical wheels and a tapered pinion (R6). One of its wheels meshes with the first wheel (R2), and the pinion acts with a crown on a shaft at right angles to the second shaft (6). A third shaft (45), parallel to the other shafts (2, 6), has a toothed cylindrical wheel (R9) meshing with the third wheel (R8) of the first shaft (2). A fourth shaft (50) has a tapered pinion (R10), with a joint (49) connection to the third shaft (45). The tapered pinion (R10) acts with a conical wheel to transmit the movement of the rotary cutting blade (L). A fifth shaft has a toothed cylindrical wheel driven by the second wheel (R3) of the first shaft (2) and, in turn, driving a wheel on a shaft. A sixth shaft has a toothed cylindrical wheel, driven by a wheel of the second shaft (6) to drive a wheel of a corresponding shaft. The wheels (R2) of one set are identical, and the wheels (R6) of another set are of the same module and have the same number of teeth. The shafts of the wheels working with the fifth shafts engage the drive wheels for the binding threads and the coils of the effect threads. The shaft for the crown gives movement to the drawing wheels to feed the binding threads, so that the rotations of the drawing wheels match the rotations of the thread guide wheels. The first two shafts (2, 6) are held in a shell structure (CF) in two sealed units (17, 18) fixed to the body (19) of the machine. The shafts are held in corresponding housings, each of two units pivoting round the first and second shaft (2, 6) on a fixed housing (CF), so that the shaft wheels can turn between a working position in contact with the wheels of the thread pitch gauge, and an inoperative setting for access to the gauge with the wheels rotating.
Patent DE-69518758-D1 (DE)
Inventor: SAARELAINEN RITVA
IPC: A23K30/00
Filed: 1995-05-23
Granted: 2000-10-12
Abstract: The invention concerns a procedure for separating from cereal a microbe inhibitor and/or combination of microbe inhibitors, the cereal being ground, the meal suspended in water in order to dissolve the soluble substances, the insoluble constituents being removed and from the solution being separated a microbe inhibitor fraction having molecular weight less than 30,000. The invention further concerns a prepared microbe inhibitor and/or combination of microbe inhibitors and the use of a microbe inhibitor and/or combination of microbe inhibitors for retarding or preventing growth of bacteria and/or fungi.
Patent DE-69520173-D1 (DE)
Inventor: BOMBARDELLI EZIO
IPC: A61K36/87
Filed: 1995-07-14
Granted: 2001-04-05
Abstract: The present invention relates to the use of coumarins such as esculoside, esculetin, extracts containing them and mixtures thereof, in combination with dimeric and oligomeric proanthocyanidins, in topical formulations for the treatment of peripheral vasculopathies, including the complications of acute venous stasis, or of the unesthetisms related to capillary alterations, or to improve the cicatrization processes. These coumarins, alone or in combination with proanthocyanidins, are also useful in atopical dermatitis and in the treatment of the haematomas.
Patent DE-69523566-D1 (DE)
Inventor: SAUNDERS M
IPC: G01N1/10
Filed: 1995-01-23
Granted: 2001-12-06
Abstract: A density gradient medium for the isolation and enrichment of rare cells, including fetal nucleated erythrocytes from a peripheral blood sample is described. The medium comprises a colloidal density gradient medium dispersed in a meltable gel. In one aspect of the invention, the density gradient medium is hypertonic to facilitate separation of maternal red blood cells from fetal blood cells.
Patent DE-69525030-D1 (DE)
Inventor: SUTHERLAND L
IPC: B65D1/00
Filed: 1995-09-12
Granted: 2002-02-21
Abstract: A wrap-around carrier having improved secondary locking means. A secondary locking tab contains a retaining opening, and one edge of a secondary locking opening includes a retaining tab which fits into the retaining opening to prevent withdrawal of the locking tab. A retaining flap engaging the secondary locking tab prevents the locking tab from moving out of engagement with the retaining tab.
Patent DE-69533146-D1 (DE)
Inventor: RYABY P
IPC: A61B17/225
Filed: 1995-03-02
Granted: 2004-07-15
Abstract: This invention relates to apparatus for providing and using a gel containment structure with an ultrasonic delivery system. The apparatus includes a special bladder (10), a cap or another enclosure means for positioning adjacent the transmitting surface (22) so that the coupling gel is retained adjacent the transmitting surface (22). <IMAGE>
Patent DE-69601511-D1 (DE)
Inventor: BOREL EDOUARD
IPC: B65H20/04
Filed: 1996-05-03
Granted: 1999-03-25
Abstract: The feeder consists of a first drive roller (10) and a satellite roller (20) which can oscillate about it between upper and rear positions on side levers (52, 53, 55) On the drive roller's shaft. The driving pinion (29) of the satellite roller (20) meshes with a toothed gear (14) of the same diameter fixed to the drive roller shaft. The feeder is equipped with a counterweight (80) which is rotated by the toothed gear (14) and is mounted on an arm (70) which pivots about the drive roller shaft (12) and is connected by a mechanism (54, 60, 61, 62, 65) to the side levers (52, 53), enabling it to oscillate in the opposite direction to the satellite roller. The counterweight is driven by a pinion (76) of the same diameter as gear (14), and has moments of inertia relative to its axis of rotation and to the axis of arm (70).
Patent DE-69605318-D1 (DE)
Inventor: SPENCER LEE
IPC: C07F19/00
Filed: 1996-09-11
Granted: 1999-12-30
Abstract: Metal complexes useful as olefin polymerization catalysts corresponding to formula (I), wherein L is a delocalized,  pi -bonded group that is bound to M, containing up to 50 nonhydrogen atoms; M is a metal of Group 3, 4 or the Lanthanide series of the Periodic Table of the Elements; Z is a covalently bound, divalent substituent of up to 50 non-hydrogen atoms having the formula: -(ER2)m-, wherein E independently each occurrence is carbon, silicon or germanium, R independently each occurrence is selected from the group consisting of C1-20 hydrocarbyl, and C1-20 hydrocarbyloxy, with the proviso that in at least one occurrence R is C1-20 hydrocarbyloxy, and m is an integer from 1 to 3; Y is a divalent ligand group comprising nitrogen, phosphorus, oxygen or sulfur, said Y containing up to 20 nonhydrogen atoms; X' is a neutral Lewis base ligand having up to 20 non-hydrogen atoms; X'' independently each occurrence is a monovalent, anionic moiety selected from hydride, halo, hydrocarbyl, silyl, germyl, hydrocarbyloxy, amide, siloxy, halohydrocarbyl, halosilyl, silylhydrocarbyl, and aminohydrocarbyl having up to 20 non-hydrogen atoms, or two X'' groups together form a divalent hydrocarbadiyl group; n is a number from 0 to 3; and p is an integer from 0 to 2.
Patent DE-69612818-D1 (DE)
Inventor: PEYRE HENRI
IPC: B62M3/00
Filed: 1996-11-12
Granted: 2001-06-21
Abstract: The fitment consists of a guide (2) and a clip (1) which engages with an automatic bicycle pedal. The guide and clip are made from two separate components which can be fitted together in two different positions. One of the components, e.g. the clip (1) has two studs (3,4) which fit into matching holes (5,6) in the other, while the guide has two projections (10,11,16,17) at each end. The clip is produced by fritting or matrixing from a special steel, and the two components can have plastic or Nylon (RTM) thickness regulating plates between them.
Patent DE-69614577-D1 (DE)
Inventor: DESANTIS JR
IPC: A61K31/445
Filed: 1996-11-06
Granted: 2001-09-20
Abstract: Pharmaceutical compositions useful in ophthalmic surgery are described. The compositions include one or more polyamine antagonists, and are useful for preventing or treating excitotoxicity associated with ophthalmic surgery. Methods of using the compositions in connection with ophthalmic surgical procedures are also described.
Patent DE-69615386-D1 (DE)
Inventor: ROOS STURE
IPC: H01H67/22
Filed: 1996-10-08
Granted: 2001-10-25
Abstract: A multiple relay arrangement comprises a common fixed part having permanent magnets, a common movable part having permanent magnets, and fixed coils having magnetically actuable movable cores connected to a respective contact means. To establish an electrical contact through the coupling means of the multiple relay arrangement, current is passed through the coil in one direction and through the remaining coils in the opposite direction. In the contact making state, the core will be repelled by the permanent magnet on the fixed part and attracted by the permanent magnet on the movable part. The coupling means connected to the core can then be used to connect together telecommunications conductors for instance. Remaining cores are attracted by the fixed permanent magnets and not moved, although the movable part will be moved away from the fixed part by virtue of the repulsion force acting between the cores and the magnets.
Patent DE-69620233-D1 (DE)
Inventor: BALAZOVSKY MARK BORISOVICH
IPC: A61K38/00
Filed: 1996-12-10
Granted: 2002-05-02
Abstract: The invention relates to medicine, in particular to pharmacology and therapy. According to the invention method of stimulating endogenous production of cytokine and hemopoietic factors comprising introducing to a mammalian body in need of stimulation of cytokine or hemopoietic factor or both, an effective amount of oxidized glutathione, its pharmaceutically acceptable salt form, or/and its pharmaceutically acceptable derivative, for a period of time to stimulate said endogenous production to obtain a therapeutic effect, wherein said oxidized glutathione, or/and its pharmaceutically acceptable salt form, or/and its pharmaceutically acceptable derivative is introduced parenterally or topically. According to the invention, oxidized glutathione or/and its pharmaceutically acceptable salt form, or/and its pharmaceutically acceptable derivative is introduced along with an extender of the half life of said oxidized glutathione or/and its pharmaceutically acceptable salt form, or/and its pharmaceutically acceptable derivative.
Patent DE-69624002-D1 (DE)
Inventor: YAMAMOTO YUJIRO
IPC: B03C3/155
Filed: 1996-07-25
Granted: 2002-10-31
Abstract: A clog-resistant filter (24) for extracting fine particulate contaminants, such as smoke, from a gaseous fluid stream, such as air, uses an induced voltage electrode (202) to efficiently capture the contaminant particles in a filter material (24) whose pores are many times larger than the diameter of the particles to be captured. The filter material (24) is physically so configured to further enhance that interaction and is disposed between at least a pair of electrodes (18, 20) of opposite polarity.
Patent DE-69625360-D1 (DE)
Inventor: FELDCAMP GEORGE
IPC: B21C25/02
Filed: 1996-07-04
Granted: 2003-01-23
Abstract: PCT No. PCT/GB96/01595 Sec. 371 Date Feb. 4, 1998 Sec. 102(e) Date Feb. 4, 1998 PCT Filed Jul. 4, 1996 PCT Pub. No. WO97/02910 PCT Pub. Date Jan. 30, 1997An extrusion die (11) comprises a die cavity (12) having a shape corresponding to the cross-sectional shape of the required extrusion, and a preform chamber (19) in communication with the die cavity (12), the preform chamber (19) being of generally similar shape to the die cavity (12) but of greater cross-sectional area, so that regions of the preform chamber (19) communicate with corresponding regions respectively of the die cavity (12). Each region of the preform chamber (19) has a bearing length (20) which is so determined in relation to its dimensions and position that, in use, extrusion material passing through each region of the preform chamber (19) is constrained to move at a velocity such that the material passes through all regions of the die cavity (12) at a substantially uniform velocity. The die cavity (12) itself is of uniform, preferably zero, bearing length so that the extrusion process is controlled solely by adjustment of the preform chamber (19), such adjustment then being readily quantifiable and repeatable.
Patent DE-69625814-D1 (DE)
Inventor: HOWELL-SMITH DAVID
IPC: F02B75/32
Filed: 1996-07-17
Granted: 2003-02-20
Abstract: PCT No. PCT/AU96/00449 Sec. 371 Date Jan. 20, 1998 Sec. 102(e) Date Jan. 20, 1998 PCT Filed Jul. 17, 1996 PCT Pub. No. WO97/04225 PCT Pub. Date Feb. 6, 1997An engine comprises two counter rotating multilobate cams which are acted upon by a pair of diametrically opposed pistons which are rigidly interlinked by connecting rods. Differential gearing is provided to time the counter rotation of the cams. The following is an examiner's statement of reasons for allowance: The prior art fails to teach or fairly suggest the invention as a whole including a shaft having a first multilobate cam axially fixed to said shaft and an adjacent second multilobate cam differentially geared to said first multilobate cam for axial counter rotation about said shaft, at least one pair of cylinders, the cylinders of each pair being diametrically opposed with respect to said shaft with said multilobate cams interposed therebetween, and a piston in each said cylinder, said pistons of a pair of cylinders being rigidly interconnected.
Patent DE-69628452-D1 (DE)
Inventor: PROCKOP J
IPC: A61K35/12
Filed: 1996-03-28
Granted: 2003-07-03
Abstract: Intravenous use of stromal cells or of a bone marrow sample from a healthy donor for the treatment of a disease, disorder or condition characterised by a bone, cartilage or lung defect.
Patent DE-69633613-D1 (DE)
Inventor: FUJII TSUNEO
IPC: A61K9/12
Filed: 1996-12-24
Granted: 2004-11-18
Abstract: An external preparation for topical administration which aims at inhibiting rejection reactions at organ or bone marrow transplantation or treating autoimmune diseases or allergic diseases and contains as the active ingredient 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol or pharmaceutically acceptable acid-addition salts thereof.
Patent DE-69634631-D1 (DE)
Inventor: HOGAN EDWARD
IPC: A61K9/24
Filed: 1996-05-08
Granted: 2005-05-25
Abstract: A method of coating a pharmaceutical substrate, especially a tablet core, wherein a pharmaceutically acceptable powder coating material comprising active material is electrostatically applied to a surface of the substrate, wherein the coated substrate constitutes a dosage unit; and a powder coating material suitable for use in the electrostatic powder coating of a pharmaceutical substrate, in which the material is pharmaceutically acceptable, is treatable to form a film coating and includes composite particles, the composite particles comprising two or more components having different physical and/or chemical properties, the material comprising active material. The pharmaceutical substrate may contain the same active material as the powder coating material or may contain a different active material from the powder material or may contain no active material.